The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Randomized phase II trial of venetoclax + fulvestrant versus fulvestrant in estrogen receptor+, HER2– locally advanced or metastatic breast cancer following recurrence or progression during or after a CDK4/6 inhibitor: VERONICA.
 
Geoffrey J Lindeman
No Relationships to Disclose
 
Aditya Bardia
No Relationships to Disclose
 
Rebecca Bowen
No Relationships to Disclose
 
Aulde Flechais
No Relationships to Disclose
 
Guiyuan Lei
No Relationships to Disclose
 
Alexandra Hogea
No Relationships to Disclose
 
Mehrdad Mobasher
No Relationships to Disclose
 
Saeed Rafii
No Relationships to Disclose